
Novartis Forecasts 5% Yearly Sales Growth
Healthcare suppliers should note rising peak-sales targets for several established Novartis drugs.
We are Main Street covers healthcare as an industry — hospital systems, pharmaceutical companies, insurers, device makers and health-technology companies as organizations. Reporting here follows what business decisions, results and transactions mean for the sector.

Healthcare suppliers should note rising peak-sales targets for several established Novartis drugs.
November 19, 2026
Milestone-Heavy Deals Shift Cancer Drug RiskBiotech developers and healthcare partners should note how up-front payments are giving way to milestone-based structures in early oncology licensing.
November 17, 2026
Gedeon Richter Agrees to Buy Mayne PharmaSuppliers and distributors of Mayne Pharma's medicines should watch shareholder approval and the Evaris divestiture before assuming ownership changes.
November 14, 2026
Big Pharma Value Rests on a Few Blockbuster DrugsHealthcare suppliers and service firms should plan partnerships around how concentrated drug revenue now is at the largest pharma companies.
November 13, 2026
Patients in China, India Push for Retail-Style CareHealth care providers in high-scoring markets should expect more patient pressure over treatment choice, pricing visibility, and payment options.
November 12, 2026
Hearing-Aid Market Growth Forecast Rises to 3-5%Hearing-care providers and suppliers should expect stronger demand as AI-enabled devices gain share across the sector.
November 11, 2026
Alcon Implantables Miss Slows Eye-Care Growth OutlookEye-care suppliers and buyers should expect slower implantables growth as Alcon narrows its full-year guidance to the low end.
November 7, 2026
New Ranking Rates 295 Medical Tourism HospitalsHospital groups and facilitators serving overseas patients now have a published comparison that can shape referral decisions.
November 7, 2026
China Hospital Procurement Pressure Slows Viatris SalesDistributors and procurement teams serving Chinese hospitals should expect slower hospital-channel growth and tighter pricing as provincial policy takes effect.
November 7, 2026
Hospital Equipment Sales Shift to Recurring FeesSuppliers selling into hospital systems should expect vendors to propose subscription-style pricing for monitoring and software.
November 6, 2026
Google Health Update Revises Resilience ScoresBusinesses that rely on health-app data should check whether previously recorded Resilience scores have changed.
Day to day, that means hospital merger activity, pharmaceutical earnings and pipeline decisions, insurer rate and coverage changes, medical device approvals and health-tech financing. Stories describe what a decision commits an organization to rather than judging its effect on care. Reimbursement rates and coverage rules set the revenue ceiling for most healthcare businesses and appear as structural constraints across the reporting. Patent cliffs, biosimilar competition and site-of-care shifts recur as the mechanisms that reshape sector economics.